These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Patients with symptoms of acute urinary infections treated with piromidic acid or sulfamethizole in general practice. A double-blind clinical controlled multicentre study]. Johansen KS; Grosen G; Holm-Nielsen E; Jacobsen J; Jensen SH; Juel-Jacobsen T; Skinhøj A; Laursen H Ugeskr Laeger; 1981 Sep; 143(39):2491-4. PubMed ID: 7029845 [No Abstract] [Full Text] [Related]
7. [In vitro activity of 2 quinoline derivatives, oxolinic and piromidic acid]. Grima P Boll Chim Farm; 1979 Jul; 118(7):363-7. PubMed ID: 526354 [No Abstract] [Full Text] [Related]
8. Pyrido[2,3-d]pyrimidine antibacterial agents. IV. Synthesis of metabolites of piromidic acid. Matsumoto J; Minamida A; Kimura Y; Minami S Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2531-6. PubMed ID: 7428132 [No Abstract] [Full Text] [Related]
9. Activity of beta-hydroxy-piromidic acid against Staphylococcus aureus and enterobacteriaceae. García-Rodriguez JA; Gómez-García AC; Rodrigo N; Sáenz MC J Antimicrob Chemother; 1982 Jun; 9(6):493-5. PubMed ID: 7107550 [No Abstract] [Full Text] [Related]
10. [Clinical study of the use of piromidic acid in urinary tract infections in pregnant and puerperal hospitalized patients]. Grossi F; Goisis F; Goisis C Clin Ter; 1979 Sep; 90(6):579-90. PubMed ID: 535334 [No Abstract] [Full Text] [Related]
11. High-performance liquid chromatographic method for the simultaneous determination of oxolinic, nalidixic and piromidic acids in cultured fish. Horii S; Yasuoka C; Matsumoto M J Chromatogr; 1987 Feb; 388(2):459-61. PubMed ID: 3558658 [No Abstract] [Full Text] [Related]
12. [Antibacterial activity of pipemidic acid]. Torosantucci A; Cialdea L; Calabrò AM; Fillini G Ann Ist Super Sanita; 1982; 18(3):467-70. PubMed ID: 7187832 [No Abstract] [Full Text] [Related]
13. Researches on antibacterial and antifungal agents. II - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid. Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N Farmaco Sci; 1984 Feb; 39(2):95-109. PubMed ID: 6425079 [TBL] [Abstract][Full Text] [Related]
14. [Nicotinic acid therapy of anuric disorders in acute & chronic renal insufficiency]. KNICK B Ther Ggw; 1959 Jun; 98(6):253-9. PubMed ID: 13676093 [No Abstract] [Full Text] [Related]
15. Metabolism of piromidic acid, a new antibacterial agent. II. In vitro metabolic pathway of piromidic acid in rats. Sekine Y; Miyamoto M; Hashimoto M; Nakamura K Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):437-42. PubMed ID: 1021250 [No Abstract] [Full Text] [Related]
16. Acute renal failure after endoscopic injection sclerotherapy: a report of two cases. Yamaga H; Hashizume M; Kitano S; Higashi H; Yoshino I; Sugimachi K Endoscopy; 1989 Jan; 21(1):43. PubMed ID: 2917537 [No Abstract] [Full Text] [Related]
18. Acute renal failure due to gabapentin. A case report and literature. Torregrosa-de Juan E; Olagüe-Díaz P; Royo-Maicas P; Fernández-Nájera E; García-Maset R Nefrologia; 2012; 32(1):130-1. PubMed ID: 22294020 [No Abstract] [Full Text] [Related]